S100A8 and S100A9 in inflammation and cancer

617Citations
Citations of this article
346Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Calprotectin (S100A8/A9), a heterodimer of the two calcium-binding proteins S100A8 and S100A9, was originally discovered as immunogenic protein expressed and secreted by neutrophils. Subsequently, it has emerged as important pro-inflammatory mediator in acute and chronic inflammation. More recently, increased S100A8 and S100A9 levels were also detected in various human cancers, presenting abundant expression in neoplastic tumor cells as well as infiltrating immune cells. Although, many possible functions have been proposed for S100A8/A9, its biological role still remains to be defined. Altogether, its expression and potential cytokine-like function in inflammation and in cancer suggests that S100A8/A9 may play a key role in inflammation-associated cancer. © 2006 Elsevier Inc. All rights reserved.

Cite

CITATION STYLE

APA

Gebhardt, C., Németh, J., Angel, P., & Hess, J. (2006). S100A8 and S100A9 in inflammation and cancer. Biochemical Pharmacology, 72(11), 1622–1631. https://doi.org/10.1016/j.bcp.2006.05.017

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free